Barclays »

Avita Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $473k 35k 13.72
2023-09-30 $63k 4.3k 14.53
2023-06-30 $85k 5.0k 16.97
2022-06-30 $0 90 0.00
2022-03-31 $34k 3.9k 8.62

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Avita Therapeutics

Vanguard Group
AWM Investment Company
Bank of New York Mellon
Dimensional Fund Advisors
Soleus Capital Management
1492 Capital Management
Charles Schwab Investment Management
AQR Capital Management
D. E. Shaw & Co
Hussman Econometrics Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Two Sigma Advisers
Bank of America Corporation
Barclays
Rhumbline Advisers

View all funds holding Avita Therapeutics